Chemistree to Invest up to $200,000 in Pure-Play Renewable Energy

Related Articles

– Update on debt restructuring

Vancouver, BC, December 2, 2021 / PRNewswire / – Chemistre Technology Inc. (CSE: CHM) (CSE: CHM.wt) (USOTCQB: CHMJF) (“The Company” or “Chemistree”), is pleased to announce that the Company has entered into a subscription agreement with Philippine Metals Inc. (“PHI”) to invest up to $ 200,000 In receipts for a subscription. PHI, an issuer of the TSX Venture Exchange, is currently working to complete a deal with a new and exciting renewable energy company focused on developing wind and solar projects in the US and Mexico markets. Power Limited (“ReVolve”).

ReVolve was established in 2012 and currently has a portfolio of 2.78 gigawatts (“GW”) of actively developing projects and another 1.30GW of Greenfield opportunities identified and in the process of conversion to the ReVolve development pipeline. ReVolve continues to register publicly through a reverse takeover of PHI, while raising two-tier capital to accelerate its expansion plans in the US.

ReVolve’s business model is based on identifying opportunities for green project development while focusing on strong renewable resource areas, proximity / availability of capacity in the local transmission network as well as environmental considerations. These projects are then transferred through the development cycle as the company obtains the federal, state and other permits and permits required for the project, as well as ensuring the connectivity capacity required for the project to begin construction.

Next, ReVolve adopts an asset monetization strategy, whereby it seeks to sell development rights to its projects to other service companies, independent power producers (IPPs) or institutional investors active in the renewable energy sector. ReVolve intends to continue to implement this strategy for its active development pipeline, while maintaining the flexibility to change this strategy if an opportunity arises to build, fund and operate a model focused on generating revenue and long-term cash flow.

Public listing through reverse takeover of PHI will allow ReVolve to take advantage of the significant growth opportunities in the North American renewable energy market as the world’s economies and major companies switch to zero carbon emissions. ReVolve is aiming for a development pipeline of at least 5GW in the region over the next three years.

President of Chemistre Carl Cotmeier Noted, “ReVolve’s investment highlights Chemistre’s thesis work as an opportunistic investment firm. With renewable energy expected to be one of the fastest growing segments of the energy industry, we are pleased to support a well-experienced team with a strong project pipeline.”

Update on debt restructuring
The extraordinary meeting of convertible bondholders in a 10% seniority of Chemistre, which began at 09:00 On November 30, 2021, In connection with the proposed amendments to the trust agreement between the company and Odyssey Trust, was rejected due to the absence of a quorum. The company has submitted a notice of reunion to be held at 09:00 (Vancouver Time) running Monday, December 20, 2021, At the Blake, Cassels & Graydon LLP offices, located at Suite 2600, Three Bentall Center, 595 Burrard Street, Vancouver, British Columbia.

About Chemistree Technology Inc.
Chemistree Technology Inc. Is an investment company with holdings in the American cannabis sector and a consumer-focused biotechnology venture. The company’s corporate strategy is to focus on opportunistic investments in a wide range of industries, and it seeks to invest in the early stages, promising companies in which it may be the leading investor and can provide companies holding consulting services, mentoring and access to the company’s investments. Management expertise. For more information, visit

The company seeks to inform shareholders that there are legal restrictions and significant regulations governing the cannabis industry in both Canada and United States.

Cannabis-related practices or activities are illegal under U.S. federal law
The terms “medical cannabis” and “recreational cannabis” do not exist under U.S. federal law. The Federal Supervised Substances Act classifies “marijuana” as a drug in Schedule I. Under U.S. federal law, a drug or substance from Program I has potential High for abuse, no medical use is acceptable in United States, And unsafe use of the drug under medical supervision. Thus, cannabis-related practices or activities, including the unrestricted, manufacturing, importing, possession, use, or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws regarding cannabis will not absolve the Company from liability under U.S. federal law. “B, nor will it provide protection for any federal proceedings that may be brought against the Company. Enforcement of federal laws in the United States will pose a significant risk to the Company’s business and any such proceeding filed against the Company may adversely affect the Company’s operations and financial performance.

Learn more about the legal status of cannabis-related activities and related risk factors, including, but not limited to, the risk of enforcement actions, risks that third-party service providers, such as banking or financial institutions, stop providing services to the company, and the risk that the company will not , From operations in the United States to the Company, are included in the prospectus, the Company’s annual information form and other documents incorporated in the reference therein and in the Company’s annual registration report Form 2A submitted.

“Carl Cotmeier”

Neither the Canadian Securities Exchange nor its market regulator (as defined in the policies of the Canadian Securities Exchange) accept responsibility for the adequacy or accuracy of this news release.

The information detailed in this news release includes forward-looking statements in accordance with applicable securities laws. Forward-looking statements are statements that refer to future events, not the past. In this context, forward-looking statements often refer to expected future business and financial performance, and often contain words such as “expected”, “believe”, “plan”, “estimate”, “expect”, “budget”, “planned” and ” Means “, statements that an action or event” may “,” may “,” could “,” should “or” will “or will occur, or other similar expressions. In particular, but without limiting the foregoing, this news release contains forward-looking statements relating to: PHI investment, bond amendments; The Company’s ability to pay future interest payments on the debentures when these payments are repaid; The company that receives the approval required for the bondholders to implement the bond amendments; And the expected results of the amendments to the debentures on the debt burden and the future activity of the Company.

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors that may result in actual results, performance or achievements, or other future events, be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. . Such factors include, but are not limited to, the risks identified in the Company’s statements and submissions to the relevant Canadian securities regulators. Forward-looking statements are made based on beliefs, assessments and opinions of management at the time of statements, and the Company does not undertake to update forward-looking statements if beliefs, assessments and opinions or other circumstances are expected to change, except as required by applicable securities laws. Investors are warned against attributing unnecessary certainty to forward-looking statements. The Company is not responsible for updating or modifying forward-looking information to reflect new events or circumstances, unless required by applicable law.

Source Chemistre Technology Inc.

Related links




Please enter your comment!
Please enter your name here

Popular Articles